Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q3 2023 Dermatology Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q3 2023 Dermatology Update

The dermatology market continues to see strong deal flow characterized by strategic add-on activity across multiple markets throughout the country. Buyer appetite for bolt-on acquisitions has primarily been focused on existing markets, as most buyers narrow their focus on building density and aligning with practices with significant synergy potential and value creation opportunity.

As debt markets continue to settle down in Q4 and into 2024, Provident expects some of the larger PE-backed platforms that have delayed processes of their own, to reengage in discussions to approach the market.

To print and download the full Dermatology Update report, please click below…

[holo_button icon=”/wp-content/uploads/2023/10/Q3-23-Dermatology.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]